Tg Therapeutics (TGTX) Asset Utilization Ratio (2018 - 2026)

Tg Therapeutics' Asset Utilization Ratio history runs 9 years deep, the most recent figure standing at 0.54 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio fell 13.68% year-over-year to 0.54 in Q1 2026; TTM through Mar 2026 was 0.54, a 13.68% decrease from a year earlier, with the FY2025 full-year figure at 0.75, up 3.57% from the prior year.
• Asset Utilization Ratio slipped to 0.54 in Q1 2026 per TGTX's latest filing, from 0.59 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.9 in Q2 2024 and bottomed at 0.01 in Q4 2022.
• The 5-year median for Asset Utilization Ratio is 0.57 (2024), against an average of 0.44.
• Across the five-year window, Asset Utilization Ratio soared 5127.3% in 2023 and retreated 25.38% in 2025, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.01 in 2022, then surged by 5127.3% to 0.71 in 2023, then declined by 20.06% to 0.57 in 2024, then climbed by 4.38% to 0.59 in 2025, then retreated by 8.45% to 0.54 in 2026.
• Per Business Quant, the three latest TGTX Asset Utilization Ratio figures stand at 0.54 (Q1 2026), 0.59 (Q4 2025), and 0.62 (Q3 2025).